<DOC>
	<DOCNO>NCT02488538</DOCNO>
	<brief_summary>Three hundred woman severe premenstrual syndrome divide 3 group use computer generate random number . Group 1 receive COC contain drospirenone ( drospirenone 3mg+Ethinylestradiol 0.03mg ; Yasmin® ScheringAG , Egypt ) daily 21 day start 3rd day menstruation addition oral fluoxetine 20 mg daily . Group 2 receive COC contain drospirenone daily 21 day start 3rd day menstruation addition daily oral placebo similar size , color structure fluoxetine . Group 3 receive oral placebo similar COC daily 21 day start 3rd day menstruation addition daily oral placebo similar size , color structure fluoxetine .</brief_summary>
	<brief_title>Combined Oral Contraceptives Fluoxetine Versus Combined Oral Contraceptives Severe Premenstrual Syndrome</brief_title>
	<detailed_description>Premenstrual syndrome ( PMS ) manifest distress physical , behavioral psychological symptom , absence organic underlie psychiatric disease , regularly recur luteal phase menstrual cycle disappear significantly improve end menstruation . Approximately 85-90 % woman may experience premenstrual emotional physical change reproductive age prevalence severe PMS range 3 % 8 % . The etiology PMS unknown cyclical ovarian activity effect estradiol progesterone serotonin gamma-amino butyric acid key factor . Absence PMS puberty , pregnancy menopause support role cyclical ovarian activity PMS etiology . PMS symptom include psychological symptom like mood swing , irritability , depression feeling control ; physical symptom like breast tenderness , bloat headache ; behavioral symptom like reduce visuospatial cognitive ability . To diagnose PMS , symptom record prospectively two cycle use symptom diary . Several symptom diary exist Daily Record Severity Problems ( DRSP ) reliable , simple patient recommend Royal College Obstetricians Gynecologists . Life style modification like stress reduction , exercise , low carbohydrate diet suggest management PMS thoroughly investigate . Pharmacological treatment PMS include COC , serotonin reuptake inhibitor gonadotrophin-releasing hormone agonist , anxiolytic , diuretic . Various treatment also recommend include acupuncture , dietary supplement , bright light therapy , PMS treatment base individual symptom , concomitant medical history need contraception . The objective study compare roles synergistic fluoxetine combine oral contraceptive ( COC ) contain Drospirenone management severe premenstrual syndrome . Three hundred woman severe premenstrual syndrome divide 3 group use computer generate random number . Group 1 receive COC contain drospirenone ( drospirenone 3mg+Ethinylestradiol 0.03mg ; Yasmin® ScheringAG , Egypt ) daily 21 day start 3rd day menstruation addition oral fluoxetine 20 mg daily . Group 2 receive COC contain drospirenone daily 21 day start 3rd day menstruation addition daily oral placebo similar size , color structure fluoxetine . Group 3 receive oral placebo similar COC daily 21 day start 3rd day menstruation addition daily oral placebo similar size , color structure fluoxetine . To diagnose PMS woman ask document symptom daily 2 month use daily record severity problem ( DRSP ) . DRSP questionnaire comprise 25 physical emotional symptom include impairment physical social activity , woman ask give score 1 6 symptom 1 = , 2 = minimal , 3 = mild , 4 = moderate , 5 = severe , 6 = extreme . The investigator add symptom score first day menses PMS exclude score &lt; 50 . If total score great 50 , investigator record two cycle symptom . If three item average score 3 ( mild ) luteal phase , investigator add score five-day interval luteal follicular phase . PMS diagnose luteal phase score 30 percent great follicular phase score 2 month . All woman psychiatric review woman underlie psychiatric disease exclude . Women unable interact socially professionally symptom consider severe PMS . All married woman advise use barrier contraceptive . All woman ask take medication 6 month record symptoms use DRSP . Women suboptimal social professional interaction consider moderate PMS . Women interference social professional activity consider mild PMS . Women day 1 DRSP score &lt; 50 woman average luteal phase score &lt; 30 % average proliferative score consider PMS .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Premenstrual Syndrome</mesh_term>
	<mesh_term>Drospirenone</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Contraceptives , Oral , Combined</mesh_term>
	<criteria>Severe PMS Regular period Underlying psychiatric disease . Body mass index &gt; 35 . Women combine oral contraceptive . History deep venous thrombosis . History deep venous thrombosis , know liver , kidney heart disease . Allergy COC fluoxetine</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>